Effects of Glycopyrrolate/Formoterol (Bevespi) on Ventilation and Gas Exchange Abnormalities in COPD Assessed by 129Xe MRI
Phase of Trial: Phase II/III
Latest Information Update: 13 Jul 2018
At a glance
- Drugs Formoterol/glycopyrrolate (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 02 Jul 2018 Status changed from not yet recruiting to recruiting.
- 12 Feb 2018 Planned End Date changed from 1 Dec 2018 to 1 Mar 2019.
- 12 Feb 2018 Planned primary completion date changed from 1 Dec 2018 to 1 Mar 2019.